Skip to main content
. 2017 Feb;4(2):109–119. doi: 10.1016/S2215-0366(16)30378-9

Table 1.

Baseline characteristics

BPI (n=155) CBT (n=154) STPP (n=156)
Age (years) 15 (11–17) 15 (12–17) 15 (11–17)
Sex
Male 40 (26%) 40 (26%) 37 (24%)
Female 115 (74%) 114 (74%) 119 (76%)
Ethnic origin
White* 121/147 (82%) 131/152 (86%) 130/151 (86%)
Region
East Anglia 61 (39%) 62 (40%) 62 (40%)
North London 43 (28%) 41 (27%) 43 (27%)
North West 51 (33%) 51 (33%) 51 (33%)
Conduct or oppositional disorder 20 (13%) 20 (13%) 16 (10%)
Self-reported depression score 46·2 (10·6) 46·2 (10·3) 45·4 (10·8)
Number of Interviewer-assessed depressive symptoms 8·4 (2·5) 8·7 (2·3) 8·3 (2·5)
SSRI prescribed before trial entry 29/153 (19%) 32/125 (21%) 28/155 (18%)
Prevalence of one or more comorbid DSM-5 axis 1 psychiatric diagnoses 71 (46%) 80 (52%) 74 (47%)
One or more recent suicide attempts 3 (2%) 2 (1%) 7 (5%)
Lifetime suicide attempts 57 (37%) 48 (31%) 55 (35%)
Recent self-harm attempts 26 (17%) 25 (16%) 34 (22%)
One or more lifetime non-suicidal self-injury episodes 87 (56%) 75 (49%) 84 (54%)
HoNOSCA score 18·9 (6·0) 18·4 (6·0) 18·3 (6·3)
EQ-5D score 0·596 (0·27) 0·578 (0·58) 0·569 (0·59)

Data are median (range), n (%), or mean (SD). BPI=brief psychological intervention. CBT=cognitive behavioural therapy. STPP=short-term psychoanalytical psychotherapy. HoNOSCA=Health of the Nation Outcome Scales for Children and Adolescents. EQ-5D=EuroQol five dimensions questionnaire.

*

Excludes 15 patients for whom ethnic group or origin was not stated or missing.

Excludes five patients with missing information.

In the previous 2 weeks.